HCW Biologics Inc. (HCWB) NASDAQ
1.79
-0.28(-13.53%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.04M |
| Enterprise Value | 6.89M |
| P/E Ratio | -2.3 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0.57 |
| Price/Book Ratio | 0.65 |
| Enterprise/Revenue | 1.38 |
| Enterprise/EBITDA | -8.61 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.25 |
| Operating Margin | -0.98 |
Management Effectiveness
| Return On Assets | -0.06 |
| Return On Equity | -1.02 |
Income Statement
| Revenue | 54,232 |
| Revenue/Share | 3.14 |
| Gross Profit | 10,846 |
| EBITDA | -5.67M |
| Net Income | -7.96M |
| Diluted EPS | -10.63 |
Balance Sheet
| Total Cash | 1.23M |
| Total Cash/Share | 0.59 |
| Total Debt | 6.58M |
| Total Debt/Equity | 1.14 |
| Current Ratio | 0.09 |
| Book Value Per Share | 2.75 |
Price History
| 52-Week Change | -75.17 |
| 52-Week High | 7.35 |
| 52-Week Low | 0.25 |
| Moving Average 50 Days | 0.77 |
| Moving Average 200 Days | 2.04 |
Statistics
| Average Volume | 20.31M |
| Shares Outstanding | 2.09M |
| % Held by Institutions | 21.44 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:40 |
| Last Split Date | April 11, 2025 |
